To date, adalimumab (ADA) is the only biotechnology drug approved for the management of
hidradenitis suppurativa (HS), an inflammatory skin condition. However, it quickly became …

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease characterized by the
presence of painful nodules, abscesses, chronically draining fistulas, and scarring in …

Hidradenitis suppurativa (HS) is a chronic, recurrent, inflammatory skin disease deriving
from the hair follicles. The formation of inflammatory nodules, abscesses, fistulas, and sinus …

Introduction Hidradenitis suppurativa (HS) is an autoinflammatory skin disease with a high
unmet need for effective medical management. Clinically, it is characterized by inflammatory …

The treatment of hidradenitis suppurativa (HS) has always been a real challenge for
dermatologists; to date, the only biologic drugs approved for HS are adalimumab, an anti …

Background Although hidradenitis suppurativa (HS) shares some transcriptomic and cellular
infiltrate features with psoriasis, their skin proteome remains unknown. Objective To define …

Hidradenitis suppurativa (HS) is an immune-mediated inflammatory disorder characterized
by deep-seated nodules, abscesses, sinus tracts and scars localized in the intertriginous …

Introduction Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. Biologic
drugs have a key role in the long-term anti-inflammatory treatment of moderate to severe …

Hidradenitis suppurativa (HS) is a debilitating, chronic,(auto) inflammatory disease primarily
affecting apocrine gland-rich areas of the body. Although pathogenic mechanisms …

Hidradenitis suppurativa (HS) is an oftentimes debilitating condition that presents with
painful nodules, abscesses, and sinus tracts. This condition is challenging to treat, in part …